Ginkgo biloba EGb 761

Tier 3 — weak evidence · Dementia symptoms · Circulation · Cognitive aging

The pharmaceutical-grade EGb 761 extract is distinct from generic ginkgo with rigorous standardisation. Multiple European trials found 240 mg/day significantly improves dementia symptoms. A 2023 Cochrane update noted modest benefits. Anticoagulant properties require supervision with blood thinners. Generic ginkgo lacks equivalent evidence.

Dose: 240 mg/day EGb 761 pharmaceutical-grade extract (not generic ginkgo); divided into 2 daily doses